Never miss a story

Get subscribed to our newsletter


×
Facebook staring at bigger problems this year, warns analyst. VOA

Already mired in controversies, social networking giant Facebook should brace itself for another tough year as its revenue growth faces risk due to increased scrutiny of the platform’s usage by marketers, according to Pivotal Research analyst Brian Wieser.

In a note published in MediaVillage on Monday, Wieser maintained his “sell” recommendation on the company’s stock.


“On a negatively revised price target for 2019, we maintain our Sell recommendation on Facebook as we think downside risks on higher costs and management changes are more pronounced now vs. before…,” Wieser said.

“…and revenue growth also faces risks as marketers enhance their scrutiny when they assess their use of the platform,” he added.

Facebook had a tough year in 2018. Scrutiny of Facebook increased manifold since it revealed earlier in 2018 how a London-based political consultancy, that worked for US President Donald Trump’s campaign, improperly got access to data of up to 87 millions users.

Appearing before a US Congress Committee in April 2018, Facebook CEO Mark Zuckerberg apologised for the Cambridge Analytica data leak scandal.


Facebook, social media. Pixabay

While Facebook was slammed for revealing the Cambridge Analytica scandal years after it got to know of it, similar allegations of inaction were also levelled at the social media site for its role in the spread of false and divisive messages by Russian-linked accounts during the 2016 US presidential election.

Again in September 2018, Facebook said that a breach had exposed data of 50 million people and then, in December, it reported another security breach where nearly 6.8 million users risked their private photos being exposed to third-party apps.

User numbers at Facebook were flat in North America and declined slightly in Europe in third-quarter information released in October, although total monthly active users worldwide went up to 2.27 billion from 2.23 billion on the previous quarter, CNBC reported.

Also Read: Patient Isolated in Swedish Hospital Amid Ebola Suspicion

In Wieser’s analysis, Facebook’s problems are unlikely to go away in 2019.

Pivotal estimates that Facebook made between $5 billion and $7 billion from Chinese advertisers in 2018, and that might also be a problem this year if economic weakness continues in China, the CNBC report said on Monday. (IANS)


Popular

Photo by Alexander Shatov on Unsplash

Twitter has confirmed that its algorithms amplify right-leaning political content.

By Nikhila Natarajan

In a continuing study on the effects of machine learning (ML) on public conversation, Twitter has confirmed that its algorithms amplify right-leaning political content. "In six out of seven countries - all but Germany - tweets posted by accounts from the political right receive more algorithmic amplification than the political left when studied as a group," Twitter blogged.

"Right-leaning news outlets, as defined by the independent organisations, see greater algorithmic amplification on Twitter compared to left-leaning news outlets." Since 2016, Twitter users are able to choose between viewing algorithmically ordered tweets first in their home timeline or viewing the most recent tweets in reverse chronological order.

"An algorithmic home timeline displays a stream of tweets from accounts we have chosen to follow on Twitter, as well as recommendations of other content Twitter thinks we might be interested in based on accounts we interact with frequently, tweets we engage with, and more. "As a result, what we see on our timeline is a function of how we interact with Twitter's algorithmic system, as well as how the system is designed."

The new research is based on tweets of elected officials of House of Commons members in Canada, the French National Assembly, the German Bundestag, House of Representatives in Japan, Congress of Deputies of Spain, House of Commons in the UK, and official and personal accounts of House of Representatives and Senate members in the US, as well as news outlets, from April 1 to August 15, 2020.

gold Apple iPhone 6s displaying Twitter logo Tweets about political content from elected officials, regardless of party or whether the party is in power, do see algorithmic amplification when compared to political content on the reverse chronological timeline. | Photo by Sara Kurfeß on Unsplash

Keep Reading Show less
Flickr

Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal.

Even as India celebrates reaching a milestone of 100 crore Covid vaccine doses, Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal. In a video shared on his Facebook and Twitter page, Bansal hailed Sonu Kumar as a "citizen celebrity".

Bansal said that Kumar not only helped "just co-workers and family but complete strangers too. With patience, empathy and uncanny jugaad". He added that Kumar joined him "many moons ago" and completed his open school from a parking lot.

"Education has helped this wonderful man enable others to get India back on track. Bravo! The CoWin portal on Thursday mentioned that a total of 100 crore vaccine doses has been administered so far to the eligible population under the vaccination drive in India, nine months after the nationwide inoculation programme was started to protect the people against Covid-19.

"It's a cause of significant celebration and happiness," Bansal said in the video. He said that while people just help a few around them, Kumar "bridged the digital gap" for 64 people, who were finding it difficult to register themselves online on the vaccine portal. Kumar said he doesn't feel that he has contributed much towards the 100 crore vaccine dose count. "I have been able to help only 64 people, if I was able to help more I would have been happier." (IANS/ MBI)


Keep Reading Show less
VOA

A health worker counts antiretroviral drug tablets for a patient at The AIDS Support Organization (TASO) in the capital Kampala, Uganda, July 12, 2012.

KAMPALA, UGANDA — Uganda has kickstarted a trial for the injectable HIV drugs cabotegravir and rilpivirine. Researchers and those living with HIV say the trial will likely end pill fatigue, fight stigma, improve adherence and ensure patients get the right dosage.

The two drugs have been in use as tablets. The World Health Organization last year licensed their use as injectables.

Keep reading... Show less